Login / Signup
Behnam Masihipour
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 2
Top Topics
Clinical Trial
Risk Factors
Phase Iii
Helicobacter Pylori
Top Venues
Evidence-based complementary and alternative medicine : eCAM
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Fariborz Mansour-Ghanaei
,
Behnam Masihipour
,
Mohammad Fathalipour
,
Soheil Hassanipour
,
Homayoon Sokhanvar
,
Alireza Mansour-Ghanaei
,
Mehrnaz Asgharnezhad
,
Farahnaz Joukar
The Efficacy, Safety, and Tolerability of Levofloxacin Quadruple Therapy for Helicobacter pylori Eradication: A Randomized, Double-Blind Clinical Trial.
Evidence-based complementary and alternative medicine : eCAM
2022 (2022)
Fariborz Mansour-Ghanaei
,
Behnam Masihipour
,
Mohammad Fathalipour
,
Soheil Hassanipour
,
Homayoon Sokhanvar
,
Alireza Mansour-Ghanaei
,
Mehrnaz Asgharnezhad
,
Farahnaz Joukar
The Efficacy, Safety, and Tolerability of Levofloxacin Quadruple Therapy for Helicobacter pylori Eradication: A Randomized, Double-Blind Clinical Trial.
Evidence-based complementary and alternative medicine : eCAM
2022 (2022)